PAO Group Inc (PAOG)

[Drugdoctor]

So you want to own this stock with 1 billion shares of .00005 conversions still on the books, and active conversions happening?

https://backend.otcmarkets.com/otcapi/company/financial-report/228116/content


Notice there are 4 0000's in front of the 5.... 70,000,000 shares convert $3000 in debt.... sheesh!

NOTE 4 – LONG-TERM DEBT
As of June 30 2019 the Company had long-term debt of $778,050 for notes payable to private lenders. These Notes have
been classified as current since they are due at this time. The Company currently has $57,950 in nine one year Convertible
Promissory Notes to the Nuemark Group LLC. Nuemark chose to convert $3,500 of debt to 70,000,000 shares of
common stock during the quarter ended June 30, 2019. The Notes carry an interest rate of 8% and are convertible at the
rate of $.00005 per share. The Company has $93,500 outstanding in six month Promissory Notes with Brian Kistler. The
notes carry interest at 15% and are currently due. Additionally the Company had consulting agreements with Mr. Kistler
and his company, New Opportunity Business Solutions, Inc. for $600,000 dating from April 27, 2008. These agreements
have been converted to Promissory Notes and were forgiven in the first quarter of 2019. The Company entered into a
financing agreement with CDN Associates LLC wherein $586,000 was provided under a one year Convertible Promissory
Note carrying 16% interest annually. The Company has borrowed $86,243 from Rising Biosciences formerly known as
Rising India, Inc. a public company on a demand note at 8% interest annually. That note was exchanged for assets in
2018. During the year 2018 the Company made a series of small loans from a private company named Text Pro. The
total amount outstanding is $28,100 on demand notes carrying interest at 8%.